Literature DB >> 10500041

Impaired pulmonary diffusion during exercise in patients with chronic heart failure.

A A Smith1, P J Cowburn, M E Parker, M Denvir, S Puri, K R Patel, J G Cleland.   

Abstract

BACKGROUND: Pulmonary diffusion is impaired at rest in patients with chronic heart failure (CHF) and has been implicated in the generation of symptoms and exercise intolerance. The aim of this study was to determine whether pulmonary diffusion is impaired during exercise in CHF, to examine its relationship to pulmonary blood flow, and to consider its functional significance in relation to metabolic gas exchange. METHODS AND
RESULTS: Carbon monoxide transfer factor (TLCO) and pulmonary blood flow (Q(C)) were measured by a rebreathe technique at rest and during steady-state cycling at 30 W in 24 CHF patients and 10 control subjects. Both patients and control subjects were able to raise TLCO and Q(C) during exercise. However, the patient group had a lower diffusion for a given blood flow (TLCO/Q(C)) both at rest (3.6+/-0.16 and 4.8+/-0.23 mL x L(-1) x mm Hg(-1); P<0.001) and during exercise (2.8+/-0.16 and 3.4+/-0.13 mL x L(-1) x mm Hg(-1) for CHF patients and control subjects, respectively; P<0.05). TLCO/Q(C) was related to the ventilatory equivalent for carbon dioxide (VEVCO(2)) production at 30 W (TLCO/Q(c) versus VEVCO(2), r = -0.58, P<0.01) and to peak exercise oxygen consumption measured during a progressive test (TLCO/Qc versus VO(2peak), r = 0.57, P<0.01) in these patients.
CONCLUSIONS: Patients with CHF are able to recruit reserves of TLCO and Q(C) during exercise. However, the TLCO/Q(C) ratio is consistently impaired in these patients and relates to both exercise hyperpnea and peak exercise oxygen consumption. Whether this impairment in alveolar gas exchange is reversible in CHF and therefore is a potential target for therapy has yet to be determined.

Entities:  

Mesh:

Year:  1999        PMID: 10500041     DOI: 10.1161/01.cir.100.13.1406

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis.

Authors:  Sarah E Baker; Eric C Wong; Courtney M Wheatley; William T Foxx-Lupo; Marina G Martinez; Mary A Morgan; Ryan Sprissler; Wayne J Morgan; Eric M Snyder
Journal:  Med Sci Sports Exerc       Date:  2012-12       Impact factor: 5.411

2.  Comparisons of Noninvasive Methods Used to Assess Exercise Stroke Volume in Heart Failure with Preserved Ejection Fraction.

Authors:  Erik H Van Iterson; Thomas P Olson; Barry A Borlaug; Bruce D Johnson; Eric M Snyder
Journal:  Med Sci Sports Exerc       Date:  2017-09       Impact factor: 5.411

3.  Relative contribution of resting haemodynamic profile and lung function to exercise tolerance in male patients with chronic heart failure.

Authors:  P Faggiano; A D'Aloia; A Gualeni; A Giordano
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

4.  Does lung diffusion impairment affect exercise capacity in patients with heart failure?

Authors:  P G Agostoni; M Bussotti; P Palermo; M Guazzi
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

Review 5.  The pulmonary circulation and exercise responses in the elderly.

Authors:  Bryan J Taylor; Bruce D Johnson
Journal:  Semin Respir Crit Care Med       Date:  2010-10-12       Impact factor: 3.119

6.  Impaired Pulmonary Diffusion in Heart Failure With Preserved Ejection Fraction.

Authors:  Thomas P Olson; Bruce D Johnson; Barry A Borlaug
Journal:  JACC Heart Fail       Date:  2016-06       Impact factor: 12.035

7.  Use of 'ideal' alveolar air equations and corrected end-tidal PCO2 to estimate arterial PCO2 and physiological dead space during exercise in patients with heart failure.

Authors:  Erik H Van Iterson; Thomas P Olson
Journal:  Int J Cardiol       Date:  2017-10-07       Impact factor: 4.164

8.  Alveolar Air and O2 Uptake During Exercise in Patients With Heart Failure.

Authors:  Erik H Van Iterson; Joshua R Smith; Thomas P Olson
Journal:  J Card Fail       Date:  2018-08-10       Impact factor: 5.712

Review 9.  Pathophysiology and Diagnosis of Pulmonary Hypertension Due to Left Heart Disease.

Authors:  Athanasios Charalampopoulos; Robert Lewis; Peter Hickey; Charlotte Durrington; Charlie Elliot; Robin Condliffe; Ian Sabroe; David G Kiely
Journal:  Front Med (Lausanne)       Date:  2018-06-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.